KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Total Non-Current Liabilities: 2018-2025

Historic Total Non-Current Liabilities for BioNTech SE (BNTX) over the last 6 years, with Sep 2025 value amounting to $749.7 million.

  • BioNTech SE's Total Non-Current Liabilities fell 10.67% to $749.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $749.7 million, marking a year-over-year decrease of 10.67%. This contributed to the annual value of $636.2 million for FY2024, which is 14.29% down from last year.
  • BioNTech SE's Total Non-Current Liabilities amounted to $749.7 million in Q3 2025, which was down 48.33% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Total Non-Current Liabilities registered a high of $1.5 billion during Q2 2025, and its lowest value of $278.4 million during Q4 2022.
  • For the 3-year period, BioNTech SE's Total Non-Current Liabilities averaged around $738.4 million, with its median value being $742.3 million (2023).
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 237.30% in 2021, then slumped by 53.47% in 2022.
  • Quarterly analysis of 5 years shows BioNTech SE's Total Non-Current Liabilities stood at $521.1 million in 2021, then crashed by 46.57% to $278.4 million in 2022, then surged by 166.60% to $742.3 million in 2023, then dropped by 14.29% to $636.2 million in 2024, then fell by 10.67% to $749.7 million in 2025.
  • Its last three reported values are $749.7 million in Q3 2025, $1.5 billion for Q2 2025, and $758.7 million during Q1 2025.